BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings
|
|
- Augustine Crawford
- 5 years ago
- Views:
Transcription
1 INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings INDIA CAPITAL GOODS Quarterly Update 26 October 2018 Top takeaways from 2QFY19 BHEL s reported earnings (Rs 1.85bn; +60% yoy) were materially lower than our and consensus estimates. If we were to adjust for forex gains and reversal of prior period depreciation, the company in fact incurred a net loss, partly due to elevated provisions. Order inflows (Rs 51.6bn) were driven by Rs 29bn of orders in the power segment for emission control equipment. Order book at Rs 1.15tn (+19% yoy) stood at 3.9x book tobill of TTM sales. Working capital intensity increased further (NWC 233 vs. 174 days 4QFY18) with increase in receivables (481 vs. 448 days) and inventory (96 vs. 79 days). BHEL announced a buyback of 189.3mn shares accounting for 5.2% of outstanding capital at the price of Rs 86/share (23% premium to CMP) leading to a cash outgo of Rs 16.3bn. Key highlights: Revenues (Rs 68bn, +5% yoy) were marginally (3%/2%) below our/consensus due to muted power segment revenues (78% of sales, +2%) though supported by strong growth in industrial revenues (+32%) on a weak base. Reported EBITDA was up 41% yoy (Rs 2.4bn vs. Rs 1.7bn yoy) on 90bps yoy expansion in EBITDA margins (3.6% vs. 2.6% yoy). Margins were supported by gross margins (41.4% vs. 40.8%) even as employee costs were up 9% qoq. However, if we were to adjust for the forex gain of Rs 2.7bn, BHEL would have reported an EBITDA loss of Rs 332mn (vs. Rs 149mn yoy). Segmentally, operating profitability was supported by Industrial segment EBIT (Rs 696mn vs. Rs 18mn yoy) while Power EBIT declined 36% because of cost provisions. Conference call takeaways Changing sales mix in favour of SEB orders coupled with elongated payment terms and zero advances on certain orders should lead to an increase in working capital. SEBs account for 53% of receivables as of September 2018 against 37% in March 2018; the share of central utilities (29% vs. 37%) and private sector (13% vs. 15%) clients has reduced. The company hopes to offset this pressure on cash flows by imputing a higher margin at the time of bidding. BHEL is well placed in Rs 250bn of orders across power (Rs 205bn), industrial (Rs 15bn), international (Rs 20bn), and spares and services (Rs 15bn). These orders include Talcher TPP (1.3GW), Sagardighi (660MW), Adilabad (800MW), emission control equipment (more than Rs 30bn), and a project in Tanzania. In addition, the management expects to submit bids for 5.7GW of projects. Outlook and valuation With healthy share of executable orders, visibility on FY19 20 revenues has materially improved, though visibility on margins is still hazy. However, we cut our FY19/20 earnings estimates by 7%/4% to factor in impact higher working capital cycle and share buyback. We revise our target price to Rs 65 (Rs 80 earlier) based on 12x FY20 PE. We maintain our Neutral rating, as we find it difficult to justify current valuations (13x FY20 PE) for single digit RoEs and no material business diversification and stretched working capital. Neutral (Maintain) CMP RS 70 / TARGET RS 65 ( 7%) COMPANY DATA O/S SHARES (MN) : 3671 MARKET CAP (RSBN) : 274 MARKET CAP (USDBN) : WK HI/LO (RS) : 108 / 65 LIQUIDITY 3M (USDMN) : 10.1 PAR VALUE (RS) : 2 SHARE HOLDING PATTERN, % Sep 18 Jun 18 Mar 18 PROMOTERS : FII / NRI : FI / MF : NON PRO : PUBLIC & OTHERS : KEY FINANCIALS Rs bn FY18 FY19E FY20E Net Sales EBIDTA Net Profit EPS, Rs PER, x EV/EBIDTA, x P/BV, x ROE, % Debt/Equity (%) CHANGE IN ESTIMATES Revised Est. % Revision Rs bn FY19E FY20E FY19E FY20E Revenue % 0.2% EBITDA % 4.8% Core PAT % 3.6% EPS (Rs) % 1.6% Jonas Bhutta ( ) jbhutta@phillipcapital.in Vikram Rawat ( ) vrawat@phillipcapital.in (Rs mn) Q2FY19 Q2FY18 Change yoy vs. expectations Comments Order book 11,53,300 9,70, % 3% Order inflows 51,590 18, % 150% Led by Rs 29bn order for emission control equipment on low base Sales 67,799 64, % 3% Muted power segments sales partly supported by strong growth in Industrials Gross margin (%) 41.4% 40.8% 54 bps 164 bps EBITDA (332) (149) 123.4% 108% Impacted by elevated employee costs and costs provisions EBITDA margin (%) 0.5% 0.2% 26 bps 680 bps Recurring PAT (772) (304) 153.8% 129% Reported PAT 1,852 1, % 30% Supported by forex gain and depreciation reversal due to change in estimate life Recurring EPS (Rs) (0.2) (0.1) 153.8% 129% Page 1 PHILLIPCAPITAL INDIA RESEARCH
2 BHEL: Quarterly results Rs mn Q2FY19 Q2FY18 Change yoy Order book 11,53,300 9,70, % Order inflows 51,590 18, % Sales 67,799 64, % Raw material 39,757 38, % % of sales 59% 59% 54 bps Gross profit 28,042 26, % Gross margin (%) 41.4% 40.8% 54 bps Employee cost 15,398 13, % % of sales 23% 22% 107 bps Other expenses 12,976 12, % % of sales 19% 19% 27 bps EBITDA (332) (149) 123.4% EBITDA margin (%) 0.5% 0.2% 26 bps Depreciation 1,610 1, % EBIT (1,942) (2,020) 3.9% EBIT margin (%) 3% 3% 26 bps Interest % Other Income 1,517 2, % PBT (1,114) (388) 187.6% Tax (343) (83) 310.8% Effective Tax rate (%) 30.8% 21.5% 923 bps Recurring PAT (772) (304) 153.8% Recurring PAT margin (%) 1.1% 0.5% 67 bps Exceptional 2,623 1, % Reported PAT 1,852 1, % Recurring EPS (Rs) (0.2) (0.1) 153.8% Source: Company, PhillipCapital India Research BHEL: Segmental results Rs mn Q2FY19 Q2FY18 Change yoy Segment Revenue Power 51,532 50, % Industrial 14,538 11, % Gross Sales 66,069 61, % Excise & service tax % Other operating income 1,730 2, % Total Operating Income 67,799 64, % Segment EBIT Power 4,257 6, % Industrial % Segment EBIT 4,953 6, % Unallocated (6,895) (8,729) 21.0% EBIT as per P&L (1,942) (2,020) 3.9% EBIT margin (%) Power 8.3% 13.2% 495 bps Industrial 4.8% 0.2% 463 bps Segment EBIT 7.5% 10.9% 338 bps Unallocated % of Sales 10.2% 13.5% 334 bps EBIT margin 2.9% 3.1% 26 bps Source: Company, PhillipCapital India Research Estimates Page 2 PHILLIPCAPITAL INDIA RESEARCH
3 BHEL: Segmental results Rs mn Q2FY19 Q4FY18 Q2FY18 Equity share capital 7,343 7,343 4,895 Reserves & Surplus 3,18,770 3,18,668 3,17,752 Networth 3,26,113 3,26,011 3,22,648 Borrowings 7, Deferred tax liabilities, net (35,482) (36,259) (39,936) Non current liabilities (28,312) (35,687) (39,158) Networth & Liabilities 2,97,800 2,90,324 2,83,490 Fixed Assets incl CWIP 31,337 32,716 34,441 Non current investments 6,738 6,907 7,359 Current investments 5,802 Investments 6,738 6,907 13,161 Non current assets 38,075 39,623 47,603 Inventories 77,466 62,588 66,682 Trade receivables 3,89,926 3,54,935 3,29,982 Cash & bank balances 70,998 1,12,912 96,443 Other assets 32,884 31,575 38,152 Current Assets 5,71,274 5,62,009 5,31,259 Trade payables 1,10,796 1,10,659 86,744 Other liabilities 1,13,860 1,13,591 1,13,121 Provisions 86,892 87,059 95,506 Current Liabilities 3,11,548 3,11,309 2,95,372 Net Current Assets 2,59,726 2,50,700 2,35,887 Total Assets 2,97,800 2,90,324 2,83,490 Working capital analysis Net working capital ex cash 1,88,728 1,37,789 1,39,444 NWC ex cash % of sales 64% 48% 50% NWC ex cash days Inventory days Receivable days Other assets days Gross working capital days Trade payable days Other liability days Provision days Current liability days Net WC Days Source: Company, PhillipCapital India Research Estimates Page 3 PHILLIPCAPITAL INDIA RESEARCH
4 Financials Income Statement Y/E Mar, Rs mn FY17 FY18 FY19e FY20e Net sales 285, , , ,180 Growth, % Total income 285, , , ,180 Raw material expenses 175, , , ,567 Employee expenses 53,946 60,265 59,614 58,988 Other Operating expenses 36,642 48,442 52,167 67,293 EBITDA (Core) 20,051 14,131 24,961 35,333 Growth, % (246.7) (29.5) Margin, % Depreciation 8,488 7,864 6,932 7,294 EBIT 11,562 6,267 18,029 28,039 Growth, % (150.2) (45.8) Margin, % Interest paid 3,506 2,546 2,616 3,364 Other Non Operating Income 7,659 6,931 6,287 4,438 Pre tax profit 15,715 10,652 21,699 29,113 Tax provided 4,437 5,965 7,378 9,899 Net Profit (adjusted) 11,278 4,688 14,321 19,215 Growth, % (200.9) (58.4) Net Profit 4,959 8,066 16,798 19,215 Unadj. shares (m) 3,671 3,671 3,482 3,482 Wtd avg shares (m) 3,671 3,671 3,482 3,482 Balance Sheet Y/E Mar, Rs mn FY17 FY18 FY19e FY20e Cash & bank 1,04,918 1,12,912 62,200 48,574 Debtors 3,18,633 3,54,935 3,94,662 4,51,067 Inventory 73,724 62,588 73,913 87,356 Loans & advances Other current assets 32,357 31,575 34,461 40,048 Total current assets 5,29,632 5,62,009 5,65,236 6,27,045 Investments 6,614 6,907 6,907 6,907 Gross fixed assets 53,725 56,261 59,278 62,285 Less: Depreciation 17,766 25,573 32,505 39,799 Add: Capital WIP 1,683 2,028 2,011 2,004 Net fixed assets 37,642 32,716 28,784 24,490 Total assets 6,12,302 6,37,892 6,37,186 6,94,701 Current liabilities 1,95,870 2,23,793 2,19,902 2,54,075 Provisions 91,929 87,059 87,735 99,951 Total current liabilities 2,87,799 3,10,852 3,07,638 3,54,026 Non current liabilities 1,558 1,029 7,529 7,529 Total liabilities 2,89,358 3,11,881 3,15,166 3,61,554 Paid up capital 4,895 7,343 6,964 6,964 Reserves & surplus 3,18,049 3,18,668 3,15,055 3,26,183 Shareholders equity 3,22,944 3,26,011 3,22,019 3,33,147 Total equity & liabilities 6,12,302 6,37,892 6,37,186 6,94,701 Source: Company, PhillipCapital India Research Estimates Cash Flow Y/E Mar, Rs mn FY17 FY18 FY19e FY20e Pre tax profit 15,715 10,652 21,699 29,113 Depreciation 8,488 7,864 6,932 7,294 Chg in working capital 101 1,331 57,153 29,047 Total tax paid 6,259 3,810 7,378 9,899 Cash flow from operating activities 5,620 9,941 39,570 3,612 Capital expenditure 3,327 2,938 3,000 3,000 Chg in investments Cash flow from investing activities 5,659 9,607 5,764 1,438 Free cash flow 40 19,548 33,806 2,174 Debt raised/(repaid) ,500 0 Dividend (incl. tax) 4,655 8,042 8,087 9,250 Cash flow from financing activities 4,697 6,710 16,906 11,451 Net chg in cash 4,737 12,838 50,712 13,625 Valuation Ratios FY17 FY18 FY19e FY20e Per Share data EPS (INR) Growth, % (200.9) (58.4) Book NAV/share (INR) FDEPS (INR) CEPS (INR) CFPS (INR) (10.5) (0.9) DPS (INR) Return ratios Return on assets (%) Return on equity (%) Return on capital employed (%) Turnover ratios Asset turnover (x) Sales/Total assets (x) Sales/Net FA (x) Working capital/sales (x) Working capital days Liquidity ratios Current ratio (x) Quick ratio (x) Interest cover (x) n/a n/a n/a n/a Dividend cover (x) Total debt/equity (%) Net debt/equity (%) (32.0) (34.3) (17.0) (12.3) Valuation PER (x) Price/Book (x) Yield (%) EV/Net sales (x) EV/EBITDA (x) EV/EBIT (x) Page 4 PHILLIPCAPITAL INDIA RESEARCH
5 Stock Price, Price Target and Rating History N (TP 207) N (TP 100) S (TP 105) S (TP 120) S (TP 120) N (TP 135) N (TP 130) N (TP 130) N (TP 100) B (TP 103) N (TP 80) 0 A 15 O 15N 15 J 16 F 16 A 16M 16 J 16 A 16 S 16 N 16D 16 F 17M 17M 17 J 17 A 17 S 17 N 17D 17 J 18 M 18A 18 J 18 J 18 S 18 Rating Methodology We rate stock on absolute return basis. Our target price for the stocks has an investment horizon of one year. Rating Criteria Definition BUY >= +15% Target price is equal to or more than 15% of current market price NEUTRAL 15% > to < +15% Target price is less than +15% but more than 15% SELL <= 15% Target price is less than or equal to 15%. Page 5 PHILLIPCAPITAL INDIA RESEARCH
6 Disclosures and Disclaimers PhillipCapital (India) Pvt. Ltd. has three independent equity research groups: Institutional Equities, Institutional Equity Derivatives, and Private Client Group. This report has been prepared by Institutional Equities Group. The views and opinions expressed in this document may, may not match, or may be contrary at times with the views, estimates, rating, and target price of the other equity research groups of PhillipCapital (India) Pvt. Ltd. This report is issued by PhillipCapital (India) Pvt. Ltd., which is regulated by the SEBI. PhillipCapital (India) Pvt. Ltd. is a subsidiary of Phillip (Mauritius) Pvt. Ltd. References to "PCIPL" in this report shall mean PhillipCapital (India) Pvt. Ltd unless otherwise stated. This report is prepared and distributed by PCIPL for information purposes only, and neither the information contained herein, nor any opinion expressed should be construed or deemed to be construed as solicitation or as offering advice for the purposes of the purchase or sale of any security, investment, or derivatives. The information and opinions contained in the report were considered by PCIPL to be valid when published. The report also contains information provided to PCIPL by third parties. The source of such information will usually be disclosed in the report. Whilst PCIPL has taken all reasonable steps to ensure that this information is correct, PCIPL does not offer any warranty as to the accuracy or completeness of such information. Any person placing reliance on the report to undertake trading does so entirely at his or her own risk and PCIPL does not accept any liability as a result. Securities and Derivatives markets may be subject to rapid and unexpected price movements and past performance is not necessarily an indication of future performance. This report does not regard the specific investment objectives, financial situation, and the particular needs of any specific person who may receive this report. Investors must undertake independent analysis with their own legal, tax, and financial advisors and reach their own conclusions regarding the appropriateness of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future prospects may not be realised. Under no circumstances can it be used or considered as an offer to sell or as a solicitation of any offer to buy or sell the securities mentioned within it. The information contained in the research reports may have been taken from trade and statistical services and other sources, which PCIL believe is reliable. PhillipCapital (India) Pvt. Ltd. or any of its group/associate/affiliate companies do not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice. Important: These disclosures and disclaimers must be read in conjunction with the research report of which it forms part. Receipt and use of the research report is subject to all aspects of these disclosures and disclaimers. Additional information about the issuers and securities discussed in this research report is available on request. Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the research analyst s personal views about all of the subject issuers and/or securities, that the analyst(s) have no known conflict of interest and no part of the research analyst s compensation was, is, or will be, directly or indirectly, related to the specific views or recommendations contained in this research report. Additional Disclosures of Interest: Unless specifically mentioned in Point No. 9 below: 1. The Research Analyst(s), PCIL, or its associates or relatives of the Research Analyst does not have any financial interest in the company(ies) covered in this report. 2. The Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the company (ies)covered in this report as of the end of the month immediately preceding the distribution of the research report. 3. The Research Analyst, his/her associate, his/her relative, and PCIL, do not have any other material conflict of interest at the time of publication of this research report. 4. The Research Analyst, PCIL, and its associates have not received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in this report, in the past twelve months. 5. The Research Analyst, PCIL or its associates have not managed or co managed in the previous twelve months, a private or public offering of securities for the company (ies) covered in this report. 6. PCIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in connection with the research report. 7. The Research Analyst has not served as an Officer, Director, or employee of the company (ies) covered in the Research report. 8. The Research Analyst and PCIL has not been engaged in market making activity for the company(ies) covered in the Research report. 9. Details of PCIL, Research Analyst and its associates pertaining to the companies covered in the Research report: Sr. no. Particulars Yes/No 1 Whether compensation has been received from the company(ies) covered in the Research report in the past 12 months for No investment banking transaction by PCIL 2 Whether Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively hold more than 1% of No the company(ies) covered in the Research report 3 Whether compensation has been received by PCIL or its associates from the company(ies) covered in the Research report No 4 PCIL or its affiliates have managed or co managed in the previous twelve months a private or public offering of securities for the No company(ies) covered in the Research report 5 Research Analyst, his associate, PCIL or its associates have received compensation for investment banking or merchant banking or brokerage services or for any other products or services from the company(ies) covered in the Research report, in the last twelve months No Independence: PhillipCapital (India) Pvt. Ltd. has not had an investment banking relationship with, and has not received any compensation for investment banking services from, the subject issuers in the past twelve (12) months, and PhillipCapital (India) Pvt. Ltd does not anticipate receiving or intend to seek compensation for investment banking services from the subject issuers in the next three (3) months. PhillipCapital (India) Pvt. Ltd is not a market maker in the securities mentioned in this research report, although it, or its affiliates/employees, may have positions in, purchase or sell, or be materially interested in any of the securities covered in the report. Suitability and Risks: This research report is for informational purposes only and is not tailored to the specific investment objectives, financial situation or particular requirements of any individual recipient hereof. Certain securities may give rise to substantial risks and may not be suitable for certain investors. Each investor must make its own determination as to the appropriateness of any securities referred to in this research report based upon the legal, tax and accounting considerations applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The value of any security may be positively or adversely affected by changes in foreign exchange or interest rates, as well as by other financial, economic, or political factors. Past performance is not necessarily indicative of future performance or results. Page 6 PHILLIPCAPITAL INDIA RESEARCH
7 Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be reliable, but neither PCIPL nor the research analyst represents or guarantees that the information contained herein is accurate or complete and it should not be relied upon as such. Opinions expressed herein are current opinions as of the date appearing on this material, and are subject to change without notice. Furthermore, PCIPL is under no obligation to update or keep the information current. Without limiting any of the foregoing, in no event shall PCIL, any of its affiliates/employees or any third party involved in, or related to computing or compiling the information have any liability for any damages of any kind including but not limited to any direct or consequential loss or damage, however arising, from the use of this document. Copyright: The copyright in this research report belongs exclusively to PCIPL. All rights are reserved. Any unauthorised use or disclosure is prohibited. No reprinting or reproduction, in whole or in part, is permitted without the PCIPL s prior consent, except that a recipient may reprint it for internal circulation only and only if it is reprinted in its entirety. Caution: Risk of loss in trading/investment can be substantial and even more than the amount / margin given by you. Investment in securities market are subject to market risks, you are requested to read all the related documents carefully before investing. You should carefully consider whether trading/investment is appropriate for you in light of your experience, objectives, financial resources and other relevant circumstances. PhillipCapital and any of its employees, directors, associates, group entities, or affiliates shall not be liable for losses, if any, incurred by you. You are further cautioned that trading/investments in financial markets are subject to market risks and are advised to seek independent third party trading/investment advice outside PhillipCapital/group/associates/affiliates/directors/employees before and during your trading/investment. There is no guarantee/assurance as to returns or profits or capital protection or appreciation. PhillipCapital and any of its employees, directors, associates, and/or employees, directors, associates of PhillipCapital s group entities or affiliates is not inducing you for trading/investing in the financial market(s). Trading/Investment decision is your sole responsibility. You must also read the Risk Disclosure Document and Do s and Don ts before investing. Kindly note that past performance is not necessarily a guide to future performance. For Detailed Disclaimer: Please visit our website For U.S. persons only: This research report is a product of PhillipCapital (India) Pvt Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances, and trading securities held by a research analyst account. This report is intended for distribution by PhillipCapital (India) Pvt Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by the U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated, and/or transmitted onward to any U.S. person, which is not a Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, PhillipCapital (India) Pvt Ltd. has entered into an agreement with a U.S. registered broker dealer, Decker & Co, LLC. Transactions in securities discussed in this research report should be effected through Decker & Co, LLC or another U.S. registered broker dealer. If Distribution is to Australian Investors This report is produced by PhillipCapital (India) Pvt Ltd and is being distributed in Australia by Phillip Capital Limited (Australian Financial Services Licence No ). This report contains general securities advice and does not take into account your personal objectives, situation and needs. Please read the Disclosures and Disclaimers set out above. By receiving or reading this report, you agree to be bound by the terms and limitations set out above. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately. PhillipCapital (India) Pvt. Ltd. Registered office: No. 1, 18th Floor, Urmi Estate, 95 Ganpatrao Kadam Marg, Lower Parel West, Mumbai Page 7 PHILLIPCAPITAL INDIA RESEARCH
KDDL (KDDL IN) In expansion mode
INSTITUTIONAL EQUITY RESEARCH KDDL (KDDL IN) In expansion mode INDIA MIDCAP Quarterly Update Top takeaways from 2QFY19 Results in line, recovery in manufacturing & strong growth in precision engineering.
More informationColgate Palmolive (CLGT IN) Volume growth revival is the biggest positive
INSTITUTIONAL EQUITY RESEARCH Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive INDIA FMCG Quarterly Update Top takeaways from Q2FY19 In line results. Benefits of gross margin improvement
More informationBHEL (BHEL IN) Margins continue to disappoint
INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Margins continue to disappoint INDIA CAPITAL GOODS Quarterly Update 6 February 2019 Top takeaways from 3QFY19 BHEL s recurring earnings (Rs 2.8bn; +31% yoy)
More informationIndo Count (ICNT IN) Cost and currency impacted the margins
INSTITUTIONAL EQUITY RESEARCH Indo Count (ICNT IN) Cost and currency impacted the margins INDIA MIDCAP TEXTILE Quarterly Update Top takeaways from 2QFY19 Results were lower than estimates on margin decline,
More informationThe India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power
INSTITUTIONAL EQUITY RESEARCH The India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power INDIA CEMENT Quarterly Update 12 November 218 Top takeaways from Q2FY19
More informationLarsen & Toubro (LT IN) Well played on all fronts but for margins
INSTITUTIONAL EQUITY RESEARCH Larsen & Toubro (LT IN) Well played on all fronts but for margins INDIA CAPITAL GOODS Quarterly Update Top takeaways from 3QFY19 Recurring PAT (Rs 20.4bn, 36% yoy) was 20%/8%
More informationLarsen & Toubro (LT IN) Shines on all parameters and we get constructive
INSTITUTIONAL EQUITY RESEARCH Larsen & Toubro (LT IN) Shines on all parameters and we get constructive INDIA CAPITAL GOODS Quarterly Update Top takeaways from 2QFY19 Recurring PAT (Rs 19.4bn, 15% yoy)
More informationManappuram Finance (MGFL IN) Healthy operating performance
INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Healthy operating performance INDIA BFSI Quarterly Update Top takeaways from Q2FY19 Operating results ahead of expectations with NII/PAT at Rs
More informationCG Power (CGPOWER IN) Analyst meet takeaways
INSTITUTIONAL EQUITY RESEARCH CG Power (CGPOWER IN) Analyst meet takeaways INDIA CAPITAL GOODS Company Update 22 November 2018 We recently interacted with the management of CG Power to better understand
More informationAtul Ltd (ATLP IN) Sustained price & AkzoNobel JV to drive value growth
INSTITUTIONAL EQUITY RESEARCH Atul Ltd (ATLP IN) Sustained price & AkzoNobel JV to drive value growth INDIA SPECIALTY CHEMICALS Quarterly Update Top takeaways from Q3FY19 Standalone sales at Rs 10.19bn
More informationManappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability
INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability INDIA BFSI Quarterly Update Top takeaways from Q1FY19 Operating results inline
More informationCeat Ltd (CEAT IN) Competitive scenario easing?
INSTITUTIONAL EQUITY RESEARCH Ceat Ltd (CEAT IN) Competitive scenario easing? INDIA AUTOMOBILES Company Update Ceat has underperformed its peers CYTD with the stock falling by more than 25% mainly because
More informationInfosys (INFO IN) Strong performance; small miss on margins maintain BUY
INSTITUTIONAL EQUITY RESEARCH Infosys (INFO IN) Strong performance; small miss on margins maintain BUY INDIA IT SERVICES Quarterly Update 11 January 2019 Infosys reported mix set of numbers this quarter
More informationNIIT Technologies (NITEC IN) Strong performance across the board; maintain BUY
INSTITUTIONAL EQUITY RESEARCH NIIT Technologies (NITEC IN) Strong performance across the board; maintain BUY INDIA IT SERVICES Quarterly Update NIIT Tech reported strong performance in this quarter delivering
More informationHDFC Bank (HDFCB IN) Continue to perform strong
INSTITUTIONAL EQUITY RESEARCH HDFC Bank (HDFCB IN) Continue to perform strong INDIA FINANCIALS Quarterly Update Top takeaways from Q3FY19 Earnings were in line with estimate. NII growth at 22% (vs expectation
More informationAarti Industries (ARTO IN) A structural specialty chemical growth play
INSTITUTIONAL EQUITY RESEARCH Aarti Industries (ARTO IN) A structural specialty chemical growth play INDIA SPECIALTY CHEMICALS Company Update We recently visited ARTO s plant in Jhagadia (Gujarat). This
More informationAsian Paints (APNT IN) Not a colorful performance
INSTITUTIONAL EQUITY RESEARCH Asian Paints (APNT IN) Not a colorful performance INDIA FMCG Quarterly Update Top takeaways from Q2FY19 Results were significantly below our estimates as: (1) it deferred
More informationdepreciation the stood at 1.4x 2%) positive impacted by impact of INR share in the room duty continue to UCP vs months
INSTITUTIONAL EQUITY Voltas Limited (VOLT IN) Strong project execution made up for a weak AC business INDIA CAPITAL GOODS Quarterly Update 7 vember 2018 Top takeaways from 2QFY19 Recurring PAT (Rs 1bn,
More informationICICI Bank (ICICIBC IN) Strong improvement in asset quality
INSTITUTIONAL EQUITY RESEARCH ICICI Bank (ICICIBC IN) Strong improvement in asset quality INDIA FINANCIALS Quarterly Update Top takeaways from Q3FY19 ICICI Bank s reported Profit after tax of Rs 16bn,
More informationCamlin Fine Sciences (CFIN IN) At the inflexion point
INSTITUTIONAL EQUITY RESEARCH Camlin Fine Sciences (CFIN IN) At the inflexion point INDIA SPECIALTY CHEMICALS Quarterly Update Top takeaways from Q2FY19 Consolidated sales at Rs 2.01bn (5% miss to our
More informationEmami (HMN IN) Seasonality jinx continues
INSTITUTIONAL EQUITY RESEARCH Emami (HMN IN) Seasonality jinx continues INDIA FMCG Quarterly Update 1 February 2019 Despite gross-margin pressure Emami s 3QFY19 was slightly above our estimates due to
More informationPhillipCapital-Actionable Trades (P-ACT)
Alternative Research INDIA 13 October 2017 armg@phillipcapital.in DAILY REPORT PhillipCapital-Actionable Trades (P-ACT) KEY POINTS» Outlook & Chart» Sharp Shooter Trading & Delivery Trades» Silent Samurai
More informationHindustan Unilever Ltd (HUVR IN) Gross margin pressure managed well
INSTITUTIONAL EQUITY RESEARCH Hindustan Unilever Ltd (HUVR IN) Gross margin pressure managed well INDIA FMCG Quarterly Update Top takeaways from Q2FY19 HUL saw its fourth consecutive quarter of double
More informationIT Services Deal Monitor: ISG 3QCY18 Takes a breather
INSTITUTIONAL EQUITY RESEARCH IT Services Deal Monitor: ISG 3QCY18 Takes a breather INDIA IT SERVICES Quarterly Update ISG announced the Q3CY18 dealflow data yesterday. The strong deal momentum of the
More informationBHEL (BHEL IN) Elevated provisions and taxes led to the disappointment
INSTITUTIONAL EQUITY RESEARCH BHEL (BHEL IN) Elevated provisions and taxes led to the disappointment INDIA CAPITAL GOODS Quarterly Update 30 May 2018 Top takeaways from 4QFY18 BHEL s recurring profit (Rs
More informationMahindra & Mahindra (MM IN) Robust quarter, largely in line
INSTITUTIONAL EQUITY RESEARCH Mahindra & Mahindra (MM IN) Robust quarter, largely in line INDIA AUTOMOBILES Quarterly Update Top takeaways from Q1FY19 Revenue at Rs 134bn was largely in line EBITDA at
More informationLarsen & Toubro (LT IN) In line results; current orders momentum is a positive
INSTITUTIONAL EQUITY RESEARCH Larsen & Toubro (LT IN) In line results; current orders momentum is a positive INDIA CAPITAL GOODS Quarterly Update Top takeaways from 4QFY18 Recurring PAT (Rs 31.8bn, flat
More informationRamkrishna Forgings (RMKF IN) Marginally ahead, story intact
INSTITUTIONAL EQUITY RESEARCH Ramkrishna Forgings (RMKF IN) Marginally ahead, story intact INDIA AUTOMOBILES Quarterly Update Top takeaways from Q4FY18 Revenue at Rs 4.4bn up 10% qoq (+52% yoy) was 1%
More informationNalco (NACL IN) Alumina volumes drive profits
INSTITUTIONAL EQUITY RESEARCH Nalco (NACL IN) Alumina volumes drive profits INDIA METALS Quarterly Update Top takeaways from Q4FY18 Net sales at Rs 28.6bn was 2% above estimates as higher alumina sales
More informationKey estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,
: price: EPS: How does our one year outlook change? We retain our negative stance on the stock. We expect s revenue to de-grow by 9% y-o-y on the back of muted execution (client side and clearance delays)
More informationBHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018
(BHEL IN) Rating: REDUCE CMP: Rs72 TP: Rs73 July 25, 2018 Q1FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating REDUCE REDUCE Target Price
More informationBHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188
RESULTS REVIEW 1QFY15 13 AUG 2014 BHEL SELL INDUSTRY CAPITAL GOODS CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188 Nifty 7,727 Sensex 25,881 KEY STOCK DATA Bloomberg/Reuters BHEL IN/BHEL.BO No. of Shares
More informationVoltas Limited (VOLT IN) Higher margins offset weak revenues
INSTITUTIONAL EQUITY RESEARCH Voltas Limited (VOLT IN) Higher margins offset weak revenues INDIA CAPITAL GOODS Quarterly Update 17 May 2018 Top takeaways from 4QFY18 Recurring PAT (Rs 1.94bn, 2% yoy) was
More informationABB India (ABB IN) Bottom cycle valuation despite stable outlook
INSTITUTIONAL EQUITY RESEARCH ABB India (ABB IN) Bottom cycle valuation despite stable outlook INDIA CAPITAL GOODS Quarterly Update Top takeaways from 2QCY18 ABB's 2QCY18 PAT (Rs 1bn, +36% yoy) was 12%
More informationFLASH NOTE Welspun India 31 Jan 17
Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 FLASH NOTE Welspun India 31 Jan 17 CMP (Rs) 76 TP (Rs) 81 Outperformer Key Figures
More informationMonetary Policy A sound monetary policy on all parameters after a long time
Mar-17 Jun-17 Sep-17 Dec-17 Mar-18 Jun-18 Sep-18 Dec-18 Dec-13 Jun-14 Dec-14 Jun-15 Dec-15 Jun-16 Dec-16 Jun-17 Dec-17 Jun-18 Dec-18 Mar-10 Jun-11 Sep-12 Dec-13 Mar-15 Jun-16 Sep-17 Dec-18 INSTITUTIONAL
More informationCoal India. Source: Company Data; PL Research
Misses estimates; Higher costs dims hope for earnings recovery February 13, 2017 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Rating Reduce Price Rs325 Target Price Rs320 Implied Upside 1.5%
More informationQ4 EARNINGS REPORT Welspun India 25 Apr 17
Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer
More informationBUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.
At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174
More informationMaruti Suzuki. Source: Company Data; PL Research
Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty
More informationIndia Banking Trends Q2FY19 results review: Early signs of the credit cost cycle normalising
INSTITUTIONAL EQUITY RESEARCH India Banking Trends Q2FY19 results review: Early signs of the credit cost cycle normalising INDIA FINANCIAL FORTNIGHTLY Private corporate banks outperformed: PBT for banks
More informationCrompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276
Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276 October 26, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E
More informationNear-term pressure, but long-term outlook positive
INDUSTRY IT CMP (as on 2 Nov 2015) Rs 1,812 Target Price Rs 2,050 Nifty 8,051 Sensex 26,559 KEY STOCK DATA Bloomberg ECLX IN No. of Shares (mn) 30 MCap (Rs bn) / ($ mn) 55/843 6m avg traded value (Rs mn)
More informationTVS Motors. Source: Company Data; PL Research
Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709
More informationInitiating Coverage. Uflex Ltd.
2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and
More informationTata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY. Stock Data. Stock Performance (%) Company Update IT Software India Research
Company Update IT Software India Research Tata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY Nifty 10,742 Sensex 35,319 Nifty PE 26.66 Sensex PE 23.48 Stock Data Sector IT Software BSE Code 500408 NSE
More informationKalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256
: price: EPS: How does our one year outlook change? We expect KPP s revenue (standalone) to grow by 21% y-o-y in FY17E backed by an order book of Rs. 91bn (1.7x FY17E book-to-bill). Both Transmission line
More informationLarsen & Toubro (LT IN)
(LT IN) Rating: BUY CMP: Rs1,321 TP: Rs1,566 July 25, 2018 Company Report Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY BUY Target Price 1,566
More informationIndia Strategy Adding currency play to consumption
INSTITUTIONAL EQUITY RESEARCH India Strategy Adding currency play to consumption INDIA STRATEGY 2 August 218 Rupee has weakened past 7 led by dollar strength. While Indian economic fundamentals remain
More informationMahindra & Mahindra. Source: Company Data; PL Research
Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty
More informationMaruti Suzuki. Source: Company Data; PL Research
Run continues, Royalty reduction positive ; Buy January 29, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs9,277
More informationCoal India. Source: Company Data; PL Research
Earnings marred by weak realisations; Downgrade to Accumulate September 14, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating Accumulate
More informationCummins India. Growth/margin bottoming. Source: Company Data; PL Research
Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%
More informationLARGE CAP & 1,970 BSE
Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)
More informationNestlé India Outlook Hazy; Valuations Prohibitive
Nestlé India Outlook Hazy; Valuations Prohibitive Nestlé India s net sales, EBITDA and net profit surged by 35% yoy, 67% yoy & 116% yoy to Rs23.5bn, Rs4.5bn & Rs2.7bn, respectively in 3QCY16. This growth
More informationCrompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research
Looking to exit overseas Power segment! May 29, 2015 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs166 Target Price Rs204
More informationManappuram Finance (MGFL IN) Operating performance was below expectation
INSTITUTIONAL EQUITY RESEARCH Manappuram Finance (MGFL IN) Operating performance was below expectation INDIA BFSI Quarterly Update Top takeaways from Q4FY18 Operating results below expectations with NII/PAT
More informationBayer Cropscience (BYRCS IN)
(BYRCS IN) Rating: ACCUMULATE CMP: Rs4,258 TP: Rs4,517 February 4, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating ACCUMULATE
More informationHOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance
RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and
More informationBUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights
JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due
More informationCummins India Ltd Bloomberg Code: KKC IN
Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn
More informationConsolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in
More informationThermax. Source: Company Data; PL Research
Near term outlook muted, working on building a strong base November 11, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price
More informationMahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)
Batlivala & Karani RESULT UPDATE Mahindra and Mahindra Maintain Outperformer LARGE CAP Share Data Reuters code Bloomberg code MAHM.BO MM IN Market cap. (US$ mn) 12,243 6M avg. daily turnover (US$ mn) 21.0
More informationMarico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015
RESULTS REVIEW 4QFY15 29 APR 2015 Marico Kaya INDUSTRY FMCG CMP (as on 28 Apr 2015) Rs 1,635 Target Price Rs 1,823 Nifty 8,240 Sensex 27,226 KEY STOCK DATA Bloomberg MAKA IN No. of Shares (mn) 13 MCap
More informationMphasis. Increased confidence on margins. Source: Company Data; PL Research
Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as
More informationApollo Tyres (APTY IN) Hungary Plant Visit: Finally benefiting from its greenfield expansion
INSTITUTIONAL EQUITY RESEARCH Apollo Tyres (APTY IN) Hungary Plant Visit: Finally benefiting from its greenfield expansion 20 June 2018 INDIA AUTOMOBILES Company Update Hungary plant visit: Key takeaways
More informationIndian Oil Corporation (IOCL IN)
(IOCL IN) Rating: ACCUMULATE CMP: Rs148 TP: Rs142 November 2, 2018 Q2FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating ACCUMULATE ACCUMULATE
More informationBUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E
Robust quarter with clear growth visibility Dilip Buildcon s (DBL) Q1FY18 sales grew 60% YoY to Rs 16.6 bn, ahead of our estimate of Rs 12.0 bn and consensus of Rs 13.6 bn. EBITDA was up 47% at Rs 3.0
More informationBUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E
RAMCO S BUY Target Price: Rs 435 Efforts on cost cutting paying off Q2 EBITDA at Rs 2.8 bn (up 30% YoY) was ahead of our estimates due to lower-than-expected costs. Average costs (excluding freight) declined
More informationSiemens. Railways and T&D driving inflows. Source: Company Data; PL Research
Railways and T&D driving inflows November 23, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,055 Target Price Rs1,230
More informationMaruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research
In a league of its own ; Buy October 28, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs8,115 Target Price Rs9,250
More informationCMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7
2QFY18 Result Update November 23, 2017 Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7 High Order Book Provides Revenue Visibility (PMPL) has delivered a healthy performance in 2QFY18.
More informationKEC International (KECI IN)
(KECI IN) Rating: BUY CMP: Rs370 TP: Rs425 June 15, 2018 Analyst Meet Update Change in Estimates Target Reco Change in Estimates Current Previous FY19E FY20E FY19E FY20E Rating BUY - Target Price 425 -
More informationCoal India (COAL IN) Strong volumes and cost control drive profitability
INSTITUTIONAL EQUITY RESEARCH Coal India (COAL IN) Strong volumes and cost control drive profitability INDIA Power Utilities Quarterly Update Top takeaways from Q3FY16 CIL continues to maintain a strong
More informationAdani Ports & SEZ Rating: Target price: EPS:
Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT
More informationVisaka Industries Ltd
Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%
More informationFineotex Chemical Ltd
Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to
More informationCMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133
4QFY17 Result Update June 06, 2017 Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133 Mixed Quarterly Performance; Volume to Remain Strong has reported a mixed performance in 4QFY17. Its blended
More informationWipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold
Wipro 4QFY18 Result Update Still not of the woods, maintain Hold Sector: Technology CMP: ` 287 Recommendation: Hold Market statistics Current stock price (`) 287 Shares O/S (cr.) 452.3 Mcap (` cr) 129,927
More informationReliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014
INDUSTRY OIL & GAS Timing is everything COMPANY UPDATE 1 OCT 2014 Reliance Industries BUY CMP (as on 30 Sep 2014) Rs 945 Target Price Rs 1,100 Nifty 7,965 Sensex 26,631 KEY STOCK DATA Bloomberg/Reuters
More informationCMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245
3QFY18 Result Update February 05, 2018 CMP* (Rs) 166 Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245 Wage Provisioning, Lower in Plant Availability Impede Earnings Growth has delivered
More informationSQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E
Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting
More informationAllcargo Logistics. Source: Company Data; PL Research
Slow capex continue to impact PES, weak show continues May 24, 2018 Keyur Pandya keyurpandya@plindia.com +912266322247 R Sreesankar rsreesankar@plindia.com +912266322214 Rating Accumulate Price Rs120 Target
More informationLarsen & Toubro Ltd.
Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Volume No.. III Issue No. 163. Larsen & Toubro Ltd. February 26, 2018 BSE Code: 500510 NSE Code: LT Reuters Code:
More informationHavells India. Q3FY17 Result Update Positive surprise; Maintain Buy. Sector: Consumer Durable CMP: ` 376. Recommendation: BUY.
Havells India Q3FY17 Result Update Positive surprise; Maintain Buy Sector: Consumer Durable CMP: ` 376 Recommendation: BUY Market statistics Current stock price (`) 376 Shares O/S (cr.) 62.5 Mcap (` cr)
More informationFY20E FY21E FY20E FY21E
(SJET IN) Rating: BUY CMP: Rs80 TP: Rs107 February 12, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price
More informationSanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation
Institutional Equity Research Key data 3 June 28 Sector Capital Goods Market Cap Rs9bn/US$.2bn 52 Wk H/L (Rs) 337/15.5 BSE Avg. daily vol. (6m) 4,437 BSE Code 5373 NSE Code SANGHVIMOV Bloomberg SGM IN
More informationCoal India. Source: Company Data; PL Research
Lower costs and higher scale off sets weaker realisations February 12, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price Rs305
More informationCoal India. Source: Company Data; PL Research
Realisations drive the beat; E auction to surprise positively in H2 November 13, 2015 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY
More informationAmber Enterprises India Ltd
3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)
More informationCummins India. Source: Company Data; PL Research
Technology leadership, cost optimization key focus October 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs852
More informationNestle India (NEST IN) Altius, Citius, Fortius
INSTITUTIONAL EQUITY RESEARCH Nestle India (NEST IN) Altius, Citius, Fortius INDIA FMCG Company Update We attended Nestle analyst meet yesterday and came pretty impressed with 1) management agility on
More informationSBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840
(SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840 July 20, 2018 Q1FY19 Result Update Continued improvement in biz yielding results Quick Pointers Company focuses to grow in protection (both segments) and
More informationAsian Paints. Source: Company Data; PL Research
Premium valuations to sustain, Accumulate October 4, 17 Amnish Aggarwal amnishaggarwal@plindia.com +91 Gaurav Jogani gauravjogani@plindia.com +91 8 Rating Accumulate Price Rs1,1 Target Price Rs1,9 Implied
More informationBharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research
Exports remain subdued, outlook better November 08, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs850 Target Price Rs957 Implied Upside 12.6% Sensex 27,591 Nifty 8,544 (Prices
More informationCummins India (KKC IN) GST led disruption in sales impacted earnings
INSTITUTIONAL EQUITY RESEARCH Cummins India (KKC IN) GST led disruption in sales impacted earnings INDIA CAPITAL GOODS Quarterly Update Top takeaways from 2QFY18 Recurring PAT (Rs 1.5bn, 22% yoy) was 25%/
More informationMaruti Suzuki (MSIL IN)
(MSIL IN) Rating: BUY CMP: Rs6,513 TP: Rs7,600 January 28, 2019 Q3FY19 Result Update Change in Estimates Target Reco Change in Estimates Current Previous FY20E FY21E FY20E FY21E Rating BUY BUY Target Price
More informationCMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630
1QFY18 Result Update July 28,2017 CMP* (Rs) 208 Bloomberg Ticker CROMPTON IN Market Cap. (Rs bn) 130.6 Free Float (%) 65.6 Shares O/S (mn) 630 Channel De-stocking Impairs Top-line; Recovery Ahead Crompton
More informationHOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights
AMBUJA S 4 MAY 2017 Quarterly Update HOLD Target Price: Rs 232 Margins to improve from Q2 Q1CY17standalone EBITDA at Rs 4.0 bn was in line withconsensus estimate.volume was up 3% YoY to 6 mnt. Realization
More information